Cellularline Group’s Post

🙌🏼 𝗦𝗲𝗻𝗰𝘂𝗿𝗲 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗯𝗲 𝗮 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗮𝗺𝗯𝗶𝘁𝗶𝗼𝘂𝘀 #𝗡𝗲𝘄𝗹𝗶𝗳𝗲 𝗣𝗿𝗼𝗷𝗲𝗰𝘁. Newlife Chips JU Project is driving us towards innovative holistic monitoring solutions, dedicated to safeguarding the health of mothers and their newborns. 👶🏼👩🏻 Sencure's role within this initiative involves the development of an integrated patch, enabling us to precisely measure electrophysiological signals in both mothers and infants, revolutionizing the way we monitor and enhance their well-being. Our Project Manager NPI, Tom van Boven, shares his enthusiasm after being among the 60+ minds at the M12 consortium meeting in Berlin’s Fraunhofer IZM: “𝘐𝘵 𝘸𝘢𝘴 𝘷𝘦𝘳𝘺 𝘨𝘰𝘰𝘥 𝘵𝘰 𝘮𝘦𝘦𝘵 𝘦𝘷𝘦𝘳𝘺𝘰𝘯𝘦 𝘧𝘢𝘤𝘦 𝘵𝘰 𝘧𝘢𝘤𝘦. 𝘞𝘦 𝘩𝘢𝘥 𝘷𝘦𝘳𝘺 𝘪𝘯𝘵𝘦𝘳𝘦𝘴𝘵𝘪𝘯𝘨 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯𝘴 𝘢𝘣𝘰𝘶𝘵 𝘵𝘩𝘦 𝘸𝘢𝘺𝘴 𝘰𝘧 𝘪𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘪𝘯𝘨 𝘢𝘭𝘭 𝘵𝘩𝘦 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘴𝘰 𝘸𝘦 𝘤𝘢𝘯 𝘱𝘳𝘰𝘷𝘪𝘥𝘦 𝘢 𝘨𝘳𝘦𝘢𝘵 𝘮𝘰𝘯𝘪𝘵𝘰𝘳𝘪𝘯𝘨 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘩𝘪𝘨𝘩-𝘳𝘪𝘴𝘬 𝘱𝘳𝘦𝘨𝘯𝘢𝘯𝘤𝘪𝘦𝘴.” We extend our heartfelt gratitude to each participant in the consortium, whose collaborative synergy is propelling innovation, and ultimately enhancing the well-being of mothers and babies globally! Newlife Chips JU Project | Fraunhofer IZM | Tom van Boven | Chips JU #NewLife #Sencure #RemoteMonitoring #maternal #neonatal

𝑹𝑹𝑫’𝒔 𝒇𝒊𝒓𝒔𝒕 𝑻𝑯𝑪𝑺 𝒑𝒓𝒐𝒋𝒆𝒄𝒕 𝑹𝑶𝑶𝑴𝑴𝑨𝑻𝑬 𝒔𝒕𝒂𝒓𝒕𝒆𝒅 𝒘𝒊𝒕𝒉 𝒂 𝒌𝒊𝒄𝒌-𝒐𝒇𝒇 𝒎𝒆𝒆𝒕𝒊𝒏𝒈 𝒊𝒏 𝒂 𝒔𝒖𝒏-𝒅𝒓𝒆𝒏𝒄𝒉𝒆𝒅 𝑭𝒍𝒐𝒓𝒆𝒏𝒄𝒆! Only a week after the start of the Tour de France in Florence it was time to launch the ROOMMATE project in the capital city of the Italian region of Tuscany. For this launch all partners from 4 EU countries (Italy, Swiss, Romania and the Netherlands) gathered in Florence at Fondazione Don Gnocchi. After a round of introduction and tour through the centre, there was time to prepare with each other the first activities of the project. The project acknowledges the need to focus our research on rehabilitation ecosystems as real contextualisation of technology in physical rehabilitation care is still lacking. Within ROOMMATE we address the barriers including sustainability issues, lack of accessibility, lack of appropriate infrastructure, and lack of digital skills of end users. Therefore the primary aim of ROOMMATE is to develop, implement and test a sustainable rehabilitation ecosystem, to innovate stroke rehabilitation pathways. ROOMMATE is our first project within the Transforming Health and Care Systems (#THCS) partnership, a cofund action under the Horizon Europe Programme. Within this project RRD will work mainly on the technical and organisational integration of the chosen healthcare technology. For a proper organisational integration we will together with all stakeholders, and we will develop patient journeys and service models. Both will also be the starting point for an extended societal impact assessments for two care systems (Italy and Romania). The following partners are part of the ROOMMATE consortium: * Fondazione Don Gnocchi (Florence, IT) * Medea Project (Florence, IT) * Dipartimento di Ingegneria Industriale from the Università degli Studi di Firenze (Florence, IT) * Carol Davila University of Medicine and Pharmacy (Bucharest, RO) * TU Delft (Delft, NL) * Roessingh Research and Development (Enschede, NL) * Emovo Care (Lausanne, CH) #project #kickoffmeeting #patientjourney #servicemodel #stakeholderinvolvement #societalimpact #healthcare #technology #rehabilitation #stroke

From Serendipity to Success: Our Journey as Co-founders Have you ever experienced those uncanny coincidences that hint at a grander design? Snahlata Singh and I, have had our fair share of these serendipitous moments throughout our careers. Back in 2020, we unknowingly published our research in the same volume of the Journal of Biosciences. We arrived at this serendipity just last week! But the coincidences didn’t stop there.. In 2017, I joined NCCS, the same year Snahlata left the institute. Although we missed each other by a whisker, our paths were destined to cross. We found ourselves in the same team at our previous organization, where we discovered our shared passion for precision medicine and biomarker research. Our collaboration was nothing short of magical. With each project, our synergy grew stronger, culminating in the decision to co-found BioMarkIQ. Today, we stand united in our mission to revolutionize diagnostic solutions and make a lasting impact on healthcare. These moments of serendipity have been more than just coincidences!! Those, who are interested in reading the serendipitous 45th volume of the Journal of Bioscience, read up here: Manasi: On Page 10: https://lnkd.in/diqDeHG9 Snahlata: On Page 97: https://lnkd.in/dv76fqwW #BioMarkIQ #CoFounders #PrecisionMedicine #Biomarkers #HealthcareInnovation #Serendipity

I'm thrilled to share that I've been privileged to contribute to the journey of making Mayo Clinic Platform a truly international distributed data network! Yesterday marked a significant milestone as we embarked on the implementation phase, welcoming ARC Innovation and Sheba Medical Center, Tel Hashomer as integral founding members of this transformative initiative. Initiated by Mayo Clinic Platform, with Mercy, Hospital Albert Einstein, University Health Network . Together, we're pioneering a new era where diverse datasets from across the globe will fuel the development of advanced AI solutions. What began as collaborative efforts among various care providers has evolved into a cohesive team, united in our mission to tackle challenges and innovate solutions. Our collective dedication is propelling us closer to realizing the vision of a vibrant and impactful data network. From Mayo Clinic - John Halamka, M.D., M.S., Maneesh Goyal, Eric Harnisch, MBA, Sana Khalid, Bianca Billingsley, MBA, PMP, SAFe POPM, Phil Fiero, Jeffrey Wu, MPH, Atul Dhanorker From University Health Network - Keith Stewart, Brad Wouters From Mercy - @Joseph kelly, Byron Yount From Hospital Albert Einstein - Edson Amaro, Rodrigo Bornhausen Demarch From ARC Innovation - Angel W. Rabinovich, benny ben lulu As people who are coming to do the work, we didn't think of taking a good picture... so this is all I have to share :) #digitalhealth #healthcare #healthdata #healthinnovation

We're thrilled to announce that SEQUOIA has partnered with the esteemed international network of medical laboratories, INVITRO! This partnership marks a significant milestone for us, akin to our collaboration with the United Nations Population Fund (UNFPA). 🌟 Benefits of Partnership for SEQUOIA 🌟 Teaming up with INVITRO signifies a major leap in our development journey. It's a testament to our dedication to advancing medical projects and underscores the fruitful four years we've invested in our creation. Moreover, this collaboration opens doors to exciting new opportunities for future partnerships with other esteemed organizations. 🌟 Benefits for SEQUOIA Users 🌟 As a token of appreciation for your continued support, we're thrilled to offer our users a fantastic perk: a 10% discount on laboratory tests at all INVITRO branches in the Republic of Belarus! Simply mention the promo code "Sequoia" or show the coupon on your phone screen from the "Checkup" tab in our app to avail of this exclusive discount. We're incredibly proud to join forces with INVITRO in our shared mission to promote better health outcomes for everyone. Curious to learn more about the journey from ideation to implementation and our exciting plans for the future? Dive into our latest blog post here: https://lnkd.in/dQCFg6A3 Got any questions or interested in potential partnerships? Drop us a message – we're all ears! #SequoiaHealth #SequoiaPower #SexualHealth #SequoiaCollaboration #Invitro #Partnership #Healthcare #Collaboration #Innovation

Last week, we achieved another important milestone for #TEHA's Life Sciences Community.    It was a pleasure to organize and moderate the roundtable discussion "Elevating Innovation in Life Sciences: Europe’s leading TTOs in the spotlight”, held at the wonderful facilities of Humanitas Research in Milan. This event marked a significant step in our journey though innovation in #LifeSciences, showcasing the pivotal role of technology transfer processes to bring innovation from bench to bedside. Many thanks to our speakers (Robert AL, MBA RTTP, Nunzio Gennaro Cifariello, E-MBA, Irene Fialka, Anji Miller Ph.D CLP RTTP, Paola Vella, Corrado Panzeri) and to the many leaders of research and innovation that participated in the discussion (Francesca Pasinelli, Fabio Terragni, Fabrizio Conicella, Vittoria Pavoncello, Emiliano Schena and many others).     Some of the key takeaways from the discussion:  - what pharma and biotech companies are really looking for is not just science, but rather a solution to a specific need. To be patient-centered, technology transfer offices (TTOs) should focus on finding solutions that can meet market demands and patients’ need. - Multidisciplinary strategies and diverse expertise are essential. Italian universities and TTOs should actively seek to educate and hire individuals with mixed scientific backgrounds, embracing multidisciplinary knowledge that spans various therapeutic areas.  - Despite progress such as the abolishment of the professors’ privilege, there are still many bureaucratic obstacles that continue to hinder the Italian competitiveness in the global arena of innovation. It is imperative to address these constraints, particularly at the public level, to accelerate the speed at which innovations enter the market.     We are very pleased to have created this opportunity for dialogue and to have highlighted the example of Humanitas as an Italian excellence in research and innovation.   #InnoTech #innovation #TechnologyTransfer 

📹 [𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗼𝗿𝘂𝗺 𝗮𝘁 𝗠𝗜𝗡𝗗 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗲𝗸] 👉 Federated Innovation @MIND is official sponsor of the 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗼𝗿𝘂𝗺, one of the leading events dedicated to the future of life sciences, organized by Cluster Nazionale Scienze della Vita ALISEI in collaboration with Fiera Milano SpA. 🔄 The forum was a crucial moment to share ideas and perspectives on the main challenges of 𝗵𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝘆𝘀𝘁𝗲𝗺𝘀, with contributions from institutions, policymakers, scientists, and businesses. 👇 Watch some of the highlights of the event, held yesterday as part of the 𝗠𝗜𝗡𝗗 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗲𝗸, with the participation of Paola Testori Coggi, Federated Innovation Ambassador Future of Health. MIND Milano Innovation District #MIW24 #MINDInnovationWeek #MINDmilano #MilanoInnovationDistrict #Betterplaces

Dr. Nilukshi Wijesuriya, affectionately known as “Nilu,” has recently been appointed Clinical Lead for Cellular Pathology. With her unique career journey, empathetic leadership style, and commitment to innovation, Nilu is set to lead her team through new challenges and advancements. Congratulations, Dr. Wijesuriya, on this well-deserved role! Read full article here: https://lnkd.in/efH9M_4V #MakingEveryTestMatter

See below for key highlights from IMF’s Innovation and Impact Report 2023! Give it a read and watch the video if you haven’t. Great stuff happening that will continue to propel our mission and help serve our Myeloma community better. #togetherwecan

🏆 Congratulations to the three teams winning the 𝗔𝗖𝗖𝗘𝗟𝗘𝗥𝗔𝗧𝗘 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝗮𝗺 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲, successfully bidding for funds to advance their translational research proposals. The winning teams, EpiSync, ApySense, and RecoverEase (in no particular order), were awarded for developing sufficiently novel research proposals that address real-life healthcare translational challenges. Participants from each team demonstrated a combination of unique knowledge, skills, experiences, and interdisciplinary teamwork. The ACCELERATE Innovation Team Challenge is initiated by the UCL Therapeutic Innovation Networks (TINs), aiming to encourage interdisciplinary collaborations and help UCL biomedical research communities upskill in translational research. Read more about the awarded projects: bit.ly/3YlgIi1 Team EpiSync: Tom Jensen, Rob Lesniak, Shirin Shahbazi Team ApySense: Mariam Basiouny, François Sicard, Mohamed Fayez, Prof. Anne Young Team RecoverEase: Sarah James, Areeba Paracha, Taner Shakir #TranslationalResearch #TranslatingUCLScience   #Collaborations #HealthcareInnovations